Provider Profile
Titilola Sode is a healthcare provider in Dallas, TX specializing in dermatopathology. Titilola trained at Georgetown University School of Medicine, graduating in 2015. Titilola is also listed as specializing in student in an organized health care education program. Medicare claims data shows Titilola provided 2,240 services to 1,676 patients. The services billed most often include pathology examination of tissue using a microscope, intermediate complexity, destruction of precancer skin growth, 2-14 growths, and special stained specimen slides to examine tissue including interpretation and report.
Summarised automatically from public NPI registry and CMS Medicare data. Not written or reviewed by this provider. Claim this profile to replace it.
License numbers are what the provider reported to NPPES when the NPI was issued or updated. NPPES does not verify licensure; confirm current standing with the state licensing board.
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
5323 HARRY HINES BLVD
Dallas, TX 75390
Within Pathology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Autoimmune & Joints
Autopsy & Forensic
Blood & Metabolism
Blood Disorders
Cancer
Cervical & Gynecologic
Digestive
Digestive System
Endocrine
Genetics
Hormones
Immune System
Infections
Kidney
Liver
Metabolic & Routine Lab
Pregnancy & Fertility
Skin Cancer
Women's Health
Autopsy & Forensic
Blood Tests
Cytology
Cytology & Screening
Genetic & Molecular Tests
Genetics
Immune & Allergy Tests
Infection Testing
Infection Tests
Lab & Blood Tests
Pathology Review
Pregnancy & Fertility
Routine Lab Tests
Tissue Biopsy
2,240 services · 1,676 patients · 14 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | Procedure | 17003 |
118 | |
| Biopsy of related skin growth, first growth | Procedure | 11102 |
44 | |
| Destruction of precancer skin growth, 1 growth | Procedure | 17000 |
40 | |
| Destruction of skin growth, 1-14 growths | Procedure | 17110 |
23 | |
| Pathology examination of tissue using a microscope, intermediate complexity | Lab test | 88305 |
1,651 | As often as other peers in Dermatopathology |
| Special stained specimen slides to examine tissue including interpretation and report | Lab test | 88313 |
67 | More often than most peers in Dermatopathology |
| Pathology examination of tissue using a microscope, moderately low complexity | Lab test | 88304 |
66 | As often as other peers in Dermatopathology |
| Special stained specimen slides to examine tissue, each additional procedure | Lab test | 88341 |
57 | |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | Office visit | 99213 |
50 | |
| Special stained specimen slides to examine tissue, initial procedure | Lab test | 88342 |
35 |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Titilola Sode is a dermatopathology in Dallas, TX. That is the designation recorded for this NPI in the federal registry.
NPI registry
Titilola Sode is listed at 5323 Harry Hines Blvd, Dallas, TX 75390. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (214) 590-8000. Guide.md cannot book appointments or pass on messages — please call the office directly.
NPI registry
Titilola Sode's National Provider Identifier is 1003203381. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Titilola Sode attended Georgetown University School of Medicine, graduating in 2015. This comes from the CMS National Downloadable File.
CMS public data
Titilola Sode has 11 years experience. Calculated from a graduation year of 2015, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Titilola Sode performs procedures including destruction of precancer skin growth, 2-14 growths, biopsy of related skin growth, first growth and destruction of precancer skin growth, 1 growth, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Titilola Sode. If this is you, claiming it is free.
Guide.md
Provider data sourced from the NPPES NPI Registry and CMS public datasets. Information is provided for reference and is not medical advice.